<sup>68</sup>Ga-PSMA-11 PET/CT will be highly impactful in the management of newly diagnosed high risk prostate cancer patients.<h4>Funding</h4>The study was funded by the German Cancer Consortium (DKTK). This evidence concerns the gene FOLH1 and Familial prostate cancer.